Merck says its antiviral pill is less effective in a final analysis.


Science
Coronavirus (2019-nCoV), Molnupiravir (Drug), Clinical Trials By BY REBECCA ROBBINS from NYT Science https://ift.tt/3cRWljD

No comments:

Post a Comment

England enjoy dominant day at Lord's to close in on series win

England enjoy day of dominance with both bat and ball to put themselves in complete control of the second Test against Pakistan, closing day...